Pegylated Recombinant Human Arginase 1

· Bio-Cancer Treatment International Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pegylated Recombinant Human Arginase 1, covering 2017-07-28 to 2021-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer [Phase 2]

See pricing